🌍 Could Europe’s low number of ongoing studies represent a greater opportunity?
If we examine the landscape of clinical research in Europe, one key trend stands out:👉Romania, Luxemburg, Serbia, Germany, Slovakia, Poland and Bulgaria show favorable figures in terms of the number of ongoing clinical trials per 1 million population. At first glance, this might seem like a limitation. In reality, it creates a strong competitive advantage […]